Quick Med Technologies Stock Performance
| QMDT Stock | USD 0.0001 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Quick Med are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Quick Med Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Quick Med is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Quick |
Quick Med Relative Risk vs. Return Landscape
If you would invest 0.01 in Quick Med Technologies on September 30, 2025 and sell it today you would earn a total of 0.00 from holding Quick Med Technologies or generate 0.0% return on investment over 90 days. Quick Med Technologies is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Quick, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Quick Med Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Quick Med's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Quick Med Technologies, and traders can use it to determine the average amount a Quick Med's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| QMDT |
Based on monthly moving average Quick Med is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Quick Med by adding Quick Med to a well-diversified portfolio.
Quick Med Fundamentals Growth
Quick Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Quick Med, and Quick Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Quick Pink Sheet performance.
| Return On Asset | -0.35 | |||
| Profit Margin | (0.77) % | |||
| Operating Margin | (0.41) % | |||
| Current Valuation | 690.71 K | |||
| Shares Outstanding | 37.35 M | |||
| Price To Earning | (1.05) X | |||
| Price To Sales | 0.52 X | |||
| Revenue | 928.49 K | |||
| EBITDA | (339.05 K) | |||
| Cash And Equivalents | 49.68 K | |||
| Total Debt | 7.91 M | |||
| Book Value Per Share | (0.24) X | |||
| Cash Flow From Operations | 62.95 K | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 723.24 K | |||
| Retained Earnings | (28.36 M) | |||
| Current Asset | 299 K | |||
| Current Liabilities | 8.59 M | |||
About Quick Med Performance
Assessing Quick Med's fundamental ratios provides investors with valuable insights into Quick Med's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Quick Med is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. The company was founded in 1997 and is headquartered in Gainesville, Florida. Quick-Med Technolog operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.Things to note about Quick Med Technologies performance evaluation
Checking the ongoing alerts about Quick Med for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Quick Med Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Quick Med generated a negative expected return over the last 90 days | |
| Quick Med has some characteristics of a very speculative penny stock | |
| Quick Med has a very high chance of going through financial distress in the upcoming years | |
| Quick Med Technologies currently holds 7.91 M in liabilities. Quick Med Technologies has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Quick Med until it has trouble settling it off, either with new capital or with free cash flow. So, Quick Med's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quick Med Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quick to invest in growth at high rates of return. When we think about Quick Med's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 928.49 K. Net Loss for the year was (713.07 K) with profit before overhead, payroll, taxes, and interest of 128.15 K. |
- Analyzing Quick Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Quick Med's stock is overvalued or undervalued compared to its peers.
- Examining Quick Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Quick Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Quick Med's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Quick Med's pink sheet. These opinions can provide insight into Quick Med's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Quick Pink Sheet Analysis
When running Quick Med's price analysis, check to measure Quick Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quick Med is operating at the current time. Most of Quick Med's value examination focuses on studying past and present price action to predict the probability of Quick Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quick Med's price. Additionally, you may evaluate how the addition of Quick Med to your portfolios can decrease your overall portfolio volatility.